Outcome after pulmonary thromboendarterectomy

Area of Science:

• Cardiology
• Pulmonary Medicine
• Surgical Innovation

Background:

• Chronic thromboembolic pulmonary hypertension (CTEPH) significantly impacts patient quality of life and prognosis.
• Pulmonary thromboendarterectomy (PTE) is a primary treatment option for eligible CTEPH patients.
• Understanding the long-term efficacy and outcomes of PTE is crucial for patient management.

Purpose of the Study:

• To evaluate the effectiveness of Pulmonary Thromboendarterectomy (PTE) in treating Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
• To assess the immediate and long-term functional status, quality of life, and survival benefits post-PTE.
• To analyze the impact of PTE on pulmonary hemodynamics and right heart function.

Main Methods:

• Retrospective analysis of patient data undergoing PTE for CTEPH.
• Assessment of hemodynamic parameters, echocardiographic findings, and lung scan perfusion.
• Longitudinal follow-up evaluating functional capacity (NYHA class), quality of life, and clinical outcomes.

Main Results:

• PTE demonstrated an immediate significant reduction in pulmonary vascular resistance and right heart pressures.
• Patients experienced substantial improvements in functional capacity, including enhanced ability to perform daily activities and return to work.
• Long-term follow-up (1-4 years) showed sustained benefits, with most patients in NYHA class I or II, reduced symptoms, and fewer hospitalizations.

Conclusions:

• Pulmonary Thromboendarterectomy (PTE) is an effective surgical intervention for Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
• The procedure offers significant, lasting improvements in patient quality of life, functional status, and potentially extends life expectancy.
• PTE leads to favorable hemodynamic changes and sustained clinical benefits, making it a vital treatment for CTEPH.